Chemomab Therapeutics Ltd. (CMMB): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

510.23M
Year ended 2025-12-31
+30.9%
3-year compound annual growth
2021-12-31: 207.47M2022-12-31: 227.59M2023-12-31: 235.00M2024-12-31: 359.05M2025-12-31: 510.23M510.23M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31510.23M+42.1%2026-03-23, From 2025-01-01
2024-12-31359.05M+52.8%2026-03-23, From 2024-01-01
2023-12-31235.00M+3.3%2026-03-23, From 2023-01-01
2022-12-31227.59M+9.7%2025-04-04, From 2022-01-01
2021-12-31207.47Mn/a2024-03-28, From 2021-01-01